Legend Biotech Corporatio... (LEGN)
NASDAQ: LEGN
· Real-Time Price · USD
34.70
-1.14 (-3.18%)
At close: Jun 17, 2025, 3:59 PM
34.70
0.01%
After-hours: Jun 17, 2025, 04:43 PM EDT
Legend Biotech Revenue Breakdown
| Period Ending | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|
| Licensing Of Intellectual Property Revenue | 4.91M | 5.63M |
| Licensing Of Intellectual Property Revenue Growth | -12.80% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|
| Europe Revenue | 47.87M | 15.07M | 328K | 3.42M |
| Europe Revenue Growth | +217.66% | +4494.51% | -90.42% | n/a |
| United States Revenue | 434.71M | 234.73M | n/a | 86.37M |
| United States Revenue Growth | +85.19% | n/a | n/a | n/a |
| China Revenue | 320K | 179K | n/a | n/a |
| China Revenue Growth | +78.77% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 72.43M | 83.13M | 79.57M | 65.42M | 50.43M | 57.03M | 49.2M | 49.18M | 40.16M | 52.5M | 42.09M | 45.49M | 33.96M | 69.95M | 31.34M | 26.03M | 22.16M | 33.35M | 15.32M | 14.06M | 9.97M | 15.42M | 6.45M | 6.64M | 3.86M |
| Selling, General, and Administrative Revenue Growth | -12.86% | +4.47% | +21.64% | +29.72% | -11.58% | +15.92% | +0.04% | +22.47% | -23.51% | +24.73% | -7.46% | +33.96% | -51.45% | +123.22% | +20.39% | +17.47% | -33.56% | +117.64% | +8.96% | +41.00% | -35.32% | +139.03% | -2.79% | +71.90% | n/a |
| Research and Development Revenue | 101.92M | 104.43M | 95.52M | 112.63M | 100.96M | 105.68M | 95.86M | 95.79M | 84.89M | 80.76M | 104.52M | 68.83M | 81.35M | 86.5M | 72.31M | 83.46M | 71.07M | 66.93M | 63.66M | 53.57M | 48M | 66.1M | 41.92M | 32.64M | 21.29M |
| Research and Development Revenue Growth | -2.40% | +9.33% | -15.19% | +11.55% | -4.47% | +10.25% | +0.07% | +12.84% | +5.12% | -22.73% | +51.85% | -15.39% | -5.96% | +19.62% | -13.35% | +17.43% | +6.18% | +5.15% | +18.83% | +11.59% | -27.37% | +57.69% | +28.42% | +53.32% | n/a |
| Sales and Marketing Revenue | 40.97M | 48.92M | 44.27M | 30.06M | 24.22M | 33.68M | 21.1M | 21.43M | 17.95M | 25.82M | 18.85M | 27.44M | 21.3M | 52.81M | 19.53M | 16.78M | 13.42M | 24.18M | 9.29M | 9.56M | 6.54M | 13.37M | 4.46M | 5.03M | 2.76M |
| Sales and Marketing Revenue Growth | -16.26% | +10.52% | +47.26% | +24.11% | -28.07% | +59.62% | -1.54% | +19.36% | -30.47% | +36.98% | -31.30% | +28.81% | -59.66% | +170.38% | +16.39% | +25.08% | -44.52% | +160.39% | -2.83% | +46.02% | -51.06% | +199.87% | -11.33% | +82.51% | n/a |